Which statement best describes the role of an LVAD in patients with advanced heart failure who are not transplant candidates?

Which statement best describes the role of an LVAD in patients with advanced heart failure who are not transplant candidates?

• A. LVADs are used only as a bridge to transplant
• B. LVADs are used as destination therapy in appropriate patients
• C. LVADs are contraindicated in all elderly patients
• D. LVADs automatically guarantee improved survival

Answer: (B)

In patients with advanced heart failure who are not transplant candidates, an LVAD provides durable mechanical circulatory support as destination therapy. This means the device is used long-term to sustain circulation and improve symptoms and quality of life when transplant is not an option. Historically LVADs were used as a bridge to transplant, but over time they became an accepted stand-alone treatment for those who won’t undergo transplantation, after trials showed meaningful survival and functional gains compared with medical therapy alone. Of course, improvement is not automatic; outcomes depend on careful patient selection and ongoing device management, and there are risks such as bleeding, infection, thrombosis, and device-related complications. Age alone isn’t a blanket contraindication, but overall comorbidity and end-organ function influence candidacy. So the best description is that LVADs are used as destination therapy in appropriate patients.

In patients with advanced heart failure who are not transplant candidates, an LVAD provides durable mechanical circulatory support as destination therapy. This means the device is used long-term to sustain circulation and improve symptoms and quality of life when transplant is not an option. Historically LVADs were used as a bridge to transplant, but over time they became an accepted stand-alone treatment for those who won’t undergo transplantation, after trials showed meaningful survival and functional gains compared with medical therapy alone. Of course, improvement is not automatic; outcomes depend on careful patient selection and ongoing device management, and there are risks such as bleeding, infection, thrombosis, and device-related complications. Age alone isn’t a blanket contraindication, but overall comorbidity and end-organ function influence candidacy. So the best description is that LVADs are used as destination therapy in appropriate patients.